SYNBIOTIC SE
SYNBIOTIC SENuWays RecommendationRecommendation
Buy
Price Target
€12.40
Upside
282.72%
Chart
- 1M
- 3M
- 6M
- YTD
- 1Y
- 3Y
€3.24
€0.14 (4.52%)
Realtime-Data from 30.06.2025 16:00:26
SYNBIOTIC is a Buy-and-Build operator in the European industrial hemp, cannabis and cannabinoid market with an objective to establish a fully integrated platform-company with activities across the entire value chain from cultivation to production and retail.
ISIN
DE000A3E5A59
Market Cap
€18.14M
Enterprise Value
€18.14M
26 week avg vol.
4984
Primar Exchange
Xetra
IPO
2019
Sector
Health Care & Pharma
Headquarters
Munich, DE
Employees
55
Incorporated
2015
CEO
Daniel Kruse
Website
Institutional Investors
47.00%
Management
7.60%
Free Float
45.40%
15.09.2025
Publication half yearly financial report
15.09.2025
Annual General Meeting
KPIs in EUR
| KPI | NaN | NaNe | NaNe |
|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 |
| EBITDA | 0.00 | 0.00 | 0.00 |
| EBIT | 0.00 | 0.00 | 0.00 |
| EPS | |||
| FCF | 0.00 | 0.00 | 0.00 |
Valuation
| KPI | NaN | NaNe | NaNe |
|---|---|---|---|
| EV / Sales | 0.00x | 0.00x | 0.00x |
| EV / EBITDA | 0.00x | 0.00x | 0.00x |
| EV / EBIT | 0.00x | 0.00x | 0.00x |
| Price / Earnings | 0.00x | 0.00x | 0.00x |
| EV / FCF | 0.00x | 0.00x | 0.00x |
Downloads
Latest Research
Initiation